Insignificant Prostate Cancer: Analysis of Pathobiological Criteria and Predictive Factors

被引：0
|
作者：
Hierro, I. [1 ]
Perez-Enriquez, J. E. [1 ]
Alvarez, M. [1 ]
Marchal, C. [1 ]
Vicioso, L. [1 ]
Gallego, E. [1 ]
Ortega, M. V. [1 ]
Perez-Villa, L. [1 ]
Machuca, F. J. [1 ]
Matilla, A. [1 ]
机构：
[1] Virgen Victoria Hosp, Malaga, Spain
来源：
LABORATORY INVESTIGATION | 2012年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
886
引用
下载
收藏
页码：212A / 213A
页数：2
相关论文
共 50 条
  • [41] Clinical Characterization of Prostate Cancer Potentially Insignificant in the Prostate Biopsy
    Hernandez-Medina, J. A.
    Garcia-Morata, F.
    Diez-Calzadilla, N.
    Martinez-Jabaloyas, J. M.
    Rodriguez-Navarro, R.
    Soriano-Sarria, P.
    Chuan-Nuez, P.
    ACTAS UROLOGICAS ESPANOLAS, 2013, 37 (01): : 27 - 32
  • [42] Redefining the Concept of Clinically Insignificant Prostate Cancer
    Frankcombe, Daisy E.
    Li, Jian
    Cohen, Ronald J.
    UROLOGY, 2020, 136 : 176 - 179
  • [43] Integrated analysis of the genomic instability of PTEN in clinically insignificant and significant prostate cancer
    Murphy, Stephen J.
    Karnes, Robert J.
    Kosari, Farhad
    Castellar, B. Edgardo R. Parilla
    Kippp, Benjamin R.
    Johnson, Sarah H.
    Terra, Simone
    Harris, Faye R.
    Halling, Geoffrey C.
    Klein, Janet L. Schaefer
    Nasir, Aqsa
    Bergstrahl, Eric
    Rangel, Laureano J.
    Sukov, William R.
    Vasmatzis, George
    Cheville, John C.
    MODERN PATHOLOGY, 2016, 29 (02) : 143 - 156
  • [44] Volume and localization of the prostate tumor as the predictive factors of the prostate cancer stage
    Urbansky, A. I.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (08) : 570 - 571
  • [45] PREDICTIVE FACTORS OF UPGRADING AND DOWNGRADING IN PATIENTS WITH PROSTATE CANCER
    Sanseverino, Roberto
    Realfonso, Tommaso
    Intilla, Olivier
    Di Mauro, Umberto
    Pistone, Antonio
    Campitelli, Antonio
    Addesso, Maria
    Napodano, Giorgio
    ANTICANCER RESEARCH, 2017, 37 (04) : 2083 - 2084
  • [46] Predictive factors in prostate cancer: Implications for decision making
    Yossepowitch, O
    Trabulsi, EJ
    Kattan, MW
    Scardino, PT
    CANCER INVESTIGATION, 2003, 21 (03) : 465 - 480
  • [47] One core gleason score 6 prostate cancer: Clinically insignificant prostate cancer?
    Schafer, Georg
    Horninger, Wolfgang
    Pelzer, Alexandre E.
    Brunner, Andrea
    Mikuz, Gregor
    Bektic, Jasmin
    Bartsch, Georg
    JOURNAL OF UROLOGY, 2008, 179 (04): : 718 - 719
  • [48] REPEAT PROSTATE BIOPSY AND THE INCREMENTAL RISK OF CLINICALLY INSIGNIFICANT PROSTATE CANCER
    Resnick, Matthew
    Lee, Daniel
    VanArsdalen, Keith
    Wein, Alan
    Malkowicz, S. Bruce
    Guzzo, Thomas
    JOURNAL OF UROLOGY, 2010, 183 (04): : E97 - E97
  • [49] The Contemporary Concept of Significant Versus Insignificant Prostate Cancer
    Ploussard, Guillaume
    Epstein, Jonathan I.
    Montironi, Rodolfo
    Carroll, Peter R.
    Wirth, Manfred
    Grimm, Marc-Oliver
    Bjartell, Anders S.
    Montorsi, Francesco
    Freedland, Stephen J.
    Erbersdobler, Andreas
    van der Kwast, Theodorus H.
    EUROPEAN UROLOGY, 2011, 60 (02) : 291 - 303
  • [50] Repeat Prostate Biopsy and the Incremental Risk of Clinically Insignificant Prostate Cancer
    Resnick, Matthew J.
    Lee, Daniel J.
    Magerfleisch, Laurie
    Vanarsdalen, Keith N.
    Tomaszewski, John E.
    Wein, Alan J.
    Malkowicz, S. Bruce
    Guzzo, Thomas J.
    UROLOGY, 2011, 77 (03) : 548 - 552
12345